RPG Life Sciences Limited (NSE:RPGLIFE)
2,396.00
+22.90 (0.96%)
Sep 9, 2025, 3:30 PM IST
RPG Life Sciences Market Cap
RPG Life Sciences has a market cap or net worth of 39.63 billion as of September 9, 2025. Its market cap has increased by 12.27% in one year.
Market Cap
39.63B
Enterprise Value
36.98B
Revenue
6.57B
Ranking
n/a
PE Ratio
21.68
Stock Price
2,396.00
Market Cap Chart
Since June 10, 2008, RPG Life Sciences's market cap has increased from 645.16M to 39.63B, an increase of 6,042.26%. That is a compound annual growth rate of 26.95%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 8, 2025 | 39.25B | 8.64% |
Dec 31, 2024 | 36.13B | 63.53% |
Dec 29, 2023 | 22.09B | 57.71% |
Dec 30, 2022 | 14.01B | 37.00% |
Dec 31, 2021 | 10.23B | 67.61% |
Dec 31, 2020 | 6.10B | 18.71% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sun Pharmaceutical Industries | 3,793.35B |
Divi's Laboratories | 1,600.11B |
Cipla | 1,253.31B |
Apollo Hospitals Enterprise | 1,119.58B |
Mankind Pharma | 1,064.67B |
Zydus Lifesciences | 1,015.94B |
Fortis Healthcare | 716.91B |
Alkem Laboratories | 637.64B |